Toronto
Canada
23
2024-05-14
22
2024-05-14
These are the the leading inventors for applications assigned to Apotex Inc.:
Apotex Inc. based in Toronto, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Oxcarbazepine extended release dosage form
#2 | 2024-01-11 ✅ Patent 12,583,860 granted on 2026-03-24Processes for the Preparation of Multicomponent Crystalline Forms of Active Pharmaceutical Ingredients Using Solvent Vapour
#3 | 2023-11-14 ✅ Patent 11,814,356 granted on 2023-11-14Salt of cabozantinib
#4 | 2022-07-28 ✅ Patent 11,667,656 granted on 2023-06-06Crystalline forms of Tenofovir alafenamide
#5 | 2022-05-12 ✅ Patent 11,377,456 granted on 2022-07-05Crystalline form of Remdesivir
#6 | 2022-04-21 ✅ Patent 11,578,025 granted on 2023-02-14Processes for the preparation of zuclomiphene intermediates
#7 | 2021-07-22 ✅ Patent 11,661,396 granted on 2023-05-30Crystalline forms of zuclomiphene citrate
#8 | 2021-05-20 ✅ Patent 11,440,871 granted on 2022-09-13Zuclomiphene salts and crystalline forms thereof
#9 | 2021-05-06 ✅ Patent 11,345,706 granted on 2022-05-31Crystalline forms of Acalabrutinib
#10 | 2021-01-21 ✅ Patent 11,236,066 granted on 2022-02-01Crystalline forms of niraparib tosylate
#11 | 2020-07-16 ✅ Patent 10,875,846 granted on 2020-12-29Processes for the preparation of Tezacaftor and intermediates thereof
#12 | 2020-07-02 ✅ Patent 11,220,500 granted on 2022-01-11Crystalline form of Valbenazine dibesylate
#13 | 2020-03-26 ✅ Patent 11,072,620 granted on 2021-07-27Crystalline forms of Ponatinib hydrochloride
#14 | 2020-03-12 ✅ Patent 10,822,309 granted on 2020-11-03Crystalline form of Eluxadoline
#15 | 2019-09-12 ✅ Patent 10,513,504 granted on 2019-12-24Processes for the preparation of apalutamide and intermediates thereof
#16 | 2019-08-29 ✅ Patent 10,513,500 granted on 2019-12-24Crystalline forms of Lesinurad
#17 | 2019-04-18 ✅ Patent 10,858,346 granted on 2020-12-08Crystalline form of lumacaftor
#18 | 2019-01-24ENHANCED LIQUID FORMULATION STABILITY OF ERYTHROPOIETIN ALPHA THROUGH PURIFICATION PROCESSING
#19 | 2018-09-13 ✅ Patent 10,351,537 granted on 2019-07-16Processes for the preparation of lesinurad and intermediates thereof
#20 | 2018-06-28 ✅ Patent 10,301,322 granted on 2019-05-28Processes for the preparation of edoxaban and intermediates thereof
#21 | 2016-01-28 ✅ Patent 10,066,001 granted on 2018-09-04Enhanced liquid formulation stability of erythropoietin alpha through purification processing
#22 | 2009-07-02 ✅ Patent 8,097,624 granted on 2012-01-17Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
#23 | 2008-04-24 ✅ Patent 7,893,269 granted on 2011-02-22Process for the manufacture of 3-hydroxy-N-alkyl-1-cycloalky1-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
Also check out Apotex Inc.'s (Toronto, Canada) applicant profile with 42 patent applications submitted.
144401 ⎘